THE BIG IDEA

The defining story of 2026–2035 is not one breakthrough but convergence: AI is becoming an operating layer for science and industry; biology is becoming increasingly programmable; machines are gaining perception and autonomy; energy systems are becoming more distributed; and digital systems are moving closer to the body, the brain and the physical world.

A decade of convergence, not science fiction

Forecasting technology is difficult because progress rarely follows a smooth line. Some innovations move from laboratory demonstration to widespread use in only a few years; others remain technically impressive but commercially distant for decades. This updated overview therefore separates capability from deployment, and distinguishes realistic near-term change from longer-range possibility.

By August 2026, several shifts are already unmistakable. Generative AI has reached mass adoption at exceptional speed, while more capable multimodal and agentic systems are moving into software development, science, medicine and business workflows. Brain–computer interfaces have progressed from laboratory decoding toward sustained at-home use in a small number of people with severe paralysis. CRISPR-based therapy is now an approved clinical reality for selected blood disorders. Quantum computing has achieved important logical-qubit and error-correction milestones but is not yet a general replacement for classical computing. 6G is in the formal standardisation phase rather than commercial deployment. Fusion continues to advance experimentally, while commercial electricity generation remains a future goal rather than a present fact.

The most useful question is therefore not “what will exist by 2035?” but “which technologies are crossing the boundary from possibility to dependable, affordable and regulated real-world use?” This page provides that map.

What has changed since 2025?

AI has accelerated from content generation toward agentic and scientific systems. The frontier now includes multimodal reasoning, coding agents, “world models”, AI-assisted drug discovery and increasingly autonomous laboratory workflows.
Neurotechnology has become more clinically credible. Implanted BCIs remain experimental, but 2025–2026 studies demonstrate real-time synthetic speech and independent long-term computer access in people with severe paralysis.
Gene editing is now medicine, not just a research platform. CRISPR therapies have regulatory approvals, while next-generation editing, personalised mRNA and in-vivo delivery are pushing toward broader disease targets.
Energy innovation is shifting from single technologies to systems. Renewables, storage, electric vehicles, smart grids and “everything-to-grid” coordination increasingly function as one flexible energy ecosystem.
Quantum progress is real but should be described precisely. Logical qubits, improved error correction and hybrid quantum–classical workflows are advancing; broad practical quantum advantage remains limited and workload-specific.
Space timelines have changed. NASA’s revised 2026 Artemis architecture now targets Artemis II in 2026, a systems test mission in 2027, and a crewed lunar-surface return in 2028.

How to read the technology horizon

NOW / SCALING

Already deployed or entering routine use. The main questions are cost, integration, safety and access.

NEXT / 2027–2030

Strong technical momentum with credible pathways to wider deployment, but important engineering or regulatory barriers remain.

HORIZON / 2030–2035+

Potentially transformative, but timing is uncertain and claims should be treated as scenarios rather than promises.

The 20 technologies to watch

The original Neurohaven categories remain a useful foundation, but their relative maturity has changed. The updated map below prioritises the direction of travel rather than hype.

Technology	Field / maturity	Where it stands in 2026	Likely 2030–2035 direction
AI & autonomous agents	Digital intelligence NOW / SCALING	Multimodal models, coding systems and early agents are widely deployed. AI is increasingly embedded in science, healthcare and enterprise systems.	More reliable agents, personalised AI, AI-assisted research and deeper automation; governance, energy demand, reliability and labour-market effects remain central.
Brain–computer interfaces	Neurotechnology NEXT / 2027–2030	Implanted systems can decode movement and speech in small clinical trials; long-term independent home use has now been demonstrated.	Communication and control for paralysis are the clearest path. Broader enhancement applications remain much more speculative.
Robotics & embodied AI	Automation NOW / SCALING	Industrial robots are mature; AI-driven warehouse, logistics and service robots are expanding; general-purpose humanoids remain early.	Better dexterity, vision-language-action models and falling hardware costs could expand robots into flexible manufacturing, care and domestic tasks.
Autonomous vehicles & drones	Mobility NOW / SELECTIVE	Driverless services operate in selected locations; autonomy remains highly geography- and use-case-dependent. Drones are routine in inspection, mapping and logistics pilots.	Wider geofenced autonomy and regulated commercial services are likely before truly universal self-driving.
Spatial computing: AR, VR & mixed reality	Human–computer interaction NOW / SCALING	Headsets and enterprise AR are established but not yet universal consumer platforms.	Lighter hardware, better displays, spatial AI and wearable interfaces may make digital information more continuously present in work, learning and entertainment.

Technology	Field / maturity	Where it stands in 2026	Likely 2030–2035 direction
6G & next-generation connectivity	Networks NEXT / 2029–2030	6G is in study and standards development, not commercial deployment. 3GPP Release 20 covers studies; normative work follows in Release 21.	Commercial 6G is expected around 2030, with integrated sensing, AI-native networking and tighter links between communications and computing.
Quantum computing	Computing HORIZON / WORKLOAD-SPECIFIC	Error correction, logical qubits and multiple hardware platforms are advancing, but useful advantage remains narrow.	Hybrid quantum–classical systems may first matter in chemistry, materials and optimisation; fault-tolerant general-purpose quantum computing remains an uncertain timeline.
CRISPR & precision gene editing	Biotechnology NOW / EARLY CLINICAL	CRISPR-based therapies are approved for selected haemoglobin disorders; base and prime editing are advancing clinically.	More in-vivo editing, improved delivery and expansion into common disease biology are plausible, alongside major safety, equity and ethics questions.
Gene, cell & personalised mRNA medicine	Medicine NOW / SCALING	Gene therapies, CAR-T and mRNA platforms are established in defined indications; manufacturing and cost remain major constraints.	More personalised cancer vaccines, in-vivo cell engineering and targeted delivery could reduce manufacturing complexity and broaden access.
Longevity & geroscience	Health science HORIZON / EVIDENCE-BUILDING	Biological-age measurement and mechanistic ageing research are active, but no intervention has been proven to dramatically extend healthy human lifespan.	The realistic goal is longer healthspan through prevention and disease-modifying therapies; claims of “age reversal” should be treated cautiously.

Technology	Field / maturity	Where it stands in 2026	Likely 2030–2035 direction
Fusion energy	Energy HORIZON / DEMONSTRATION	Inertial and magnetic-confinement programmes continue to improve performance; commercial net-electric fusion is not yet available.	Pilot plants may emerge in the 2030s, but cost, materials, fuel cycles, maintenance and grid economics remain unresolved.
Synthetic biology & biomanufacturing	Biotechnology / Industry NOW / SCALING	Engineered cells and microbes already produce medicines, enzymes, foods and speciality chemicals.	AI-guided protein design, precision fermentation and automated biofoundries could shift more manufacturing from petrochemical to biological processes.
Advanced nuclear: SMRs & new reactors	Energy NEXT / 2027–2035	Multiple designs are under licensing or construction; deployment pace differs sharply by country and design.	SMRs may add firm low-carbon power where economics, regulation, fuel and supply chains are favourable; large-scale impact is not guaranteed.
Next-generation solar & wind	Energy NOW / RAPID SCALING	Solar and wind are mature and expanding rapidly; innovation is increasingly about efficiency, materials, grids and deployment.	Perovskite-silicon tandems, larger offshore wind, digital optimisation and improved recycling could lower lifecycle cost further.
Advanced energy storage & smart grids	Energy systems NOW / RAPID SCALING	Lithium-ion dominates, while sodium-ion, long-duration storage, solid-state approaches and grid software are progressing.	Storage will diversify by use case; distributed batteries and vehicle-to-grid systems may become active grid infrastructure.

Technology	Field / maturity	Where it stands in 2026	Likely 2030–2035 direction
Hydrogen, e-fuels & industrial decarbonisation	Energy / Industry NEXT / SELECTIVE	Low-carbon hydrogen projects are growing, but costs, infrastructure and conversion losses limit broad use.	Most valuable in hard-to-electrify sectors such as fertiliser, steel, shipping fuels and some industrial heat rather than universal household energy.
Moon-to-Mars exploration	Space NEXT / PROGRAMME-DEPENDENT	NASA’s 2026 architecture targets Artemis II in 2026, a 2027 integrated systems test and a crewed lunar-surface return in 2028.	Sustained lunar operations, science infrastructure and technology demonstrations may prepare for later Mars missions, but schedules remain highly changeable.
Commercial space economy	Space / Industry NOW / SCALING	Reusable launch, satellite constellations and commercial Earth observation are established markets; private human spaceflight remains small.	In-orbit servicing, private stations, lunar logistics and specialised manufacturing may grow, while space debris and regulation become more important.
Advanced materials & nanotechnology	Materials science NOW / CONTINUOUS	Graphene, metamaterials, 2D materials and advanced composites have strong research activity but uneven commercial penetration.	The biggest gains may come through specific applications: semiconductors, batteries, sensors, coatings, photonics and lightweight structures.
Additive manufacturing / 3D printing	Manufacturing NOW / MATURE-NICHE	Widely used for prototyping and increasingly for aerospace, medical implants, tooling and low-volume production.	More multi-material, metal, bioprinting and distributed manufacturing, with adoption governed by speed, certification and cost.

Five forces likely to shape the decade

1. AI becomes infrastructure

AI is moving from a destination app to a layer inside operating systems, research tools, clinical workflows, robotics, design software and industrial control. The most consequential shift may be from systems that answer questions to systems that can plan, use tools, call other software and complete bounded tasks. The limiting factors are increasingly reliability, security, provenance, compute, energy use and governance rather than raw demonstration capability.

2. Biology becomes more programmable

Gene editing, synthetic biology, mRNA platforms, cell therapies, organoid models and AI protein design are converging. The result is a gradual move from discovering medicines mainly by screening toward designing biological interventions with increasing precision. Delivery into the correct tissue, long-term safety, manufacturing scale and affordability remain major bottlenecks.

3. Computing moves into the physical world

Robots, autonomous vehicles, drones, spatial computing and sensor-rich environments connect digital intelligence to action. “Embodied AI” is important because the physical world is less predictable than text or images: systems must perceive, act, recover from errors and operate safely around people.

4. Energy becomes more distributed and intelligent

The energy transition is no longer only a story about building renewable generators. It increasingly depends on storage, transmission, demand flexibility, power electronics, software, electric vehicles and industrial electrification. The grid itself is becoming a programmable system.

5. Human–machine boundaries become less distinct

Wearables, medical implants, BCIs, digital therapeutics, AI assistants and immersive interfaces are gradually bringing computation closer to the body and cognition. Medical restoration is likely to remain the strongest near-term case for invasive neurotechnology; consumer enhancement is far less certain.

What could change everyday life first?

The technologies with the greatest near-term public impact are not necessarily the most futuristic. Between now and 2030, the most visible changes are likely to come from combinations of technologies already moving into deployment:

AI assistants that can work across documents, software, search, communication and specialist tools rather than answering isolated prompts.
Robotics and automation in warehouses, manufacturing, logistics, inspection, agriculture and selected service roles.
More personalised medicine through genomics, AI-assisted diagnostics, targeted therapies and faster drug-development cycles.
Cheaper renewable electricity paired with batteries, smart-grid coordination and flexible demand.
Increasingly capable driver-assistance and geographically limited autonomous transport rather than instant universal self-driving.
Wearable and spatial interfaces that make computing less screen-bound, although phones and conventional displays are unlikely to disappear quickly.

The technologies most vulnerable to hype

Some fields are genuinely advancing while still attracting timelines that run ahead of evidence. A responsible overview should make this explicit.

Artificial general intelligence (AGI): There is no universally accepted scientific threshold or timetable. Rapid capability gains do not make a specific AGI date predictable.
Quantum computing: Progress in hardware and error correction is substantial, but “quantum advantage” is task-specific and does not imply that ordinary computers will soon be replaced.
Fusion power: Scientific milestones do not equal a commercially competitive power station. Engineering availability, maintenance, fuel cycles and economics matter as much as plasma performance.
Longevity: Improving healthspan is a credible scientific goal. Claims of dramatic human lifespan extension or routine age reversal remain unproven.
Brain enhancement: Restorative BCIs for severe disability are advancing. Elective consumer implants that reliably enhance intelligence or memory are a much more speculative proposition.
Fully autonomous transport everywhere: Autonomy works best in constrained operational domains. Weather, road complexity, edge cases, liability and regulation make universal deployment slower than headline demonstrations suggest.

A better way to think about “the future”

Technologies rarely arrive as single dramatic events. They diffuse through society unevenly. A medical breakthrough may be scientifically possible years before it is affordable. A robot may work brilliantly in a structured warehouse but fail in an ordinary home. A quantum processor may outperform classical methods on a specialised benchmark while remaining irrelevant to everyday computing. A new energy technology may function technically but still lose on economics, regulation or infrastructure.

For that reason, Neurohaven’s Future Science section should be read as an evidence-informed horizon scan rather than a collection of predictions. The aim is to explain what each technology does, why it matters, how mature it really is, what barriers remain and what would have to happen for it to affect ordinary life.

Six questions to ask of every breakthrough

Question	Why it matters
Does it work outside the lab?	Controlled demonstrations are different from robust performance in hospitals, homes, roads, factories or power systems.
Can it scale?	A technology can be scientifically valid yet limited by manufacturing, materials, workforce, supply chains or infrastructure.
Is it affordable?	Adoption depends on total cost, not only technical performance.
Is it safe and governable?	Clinical regulation, cybersecurity, privacy, liability and environmental effects can determine the real deployment pace.
Does it solve a problem better than alternatives?	A new technology must usually beat an existing solution on cost, performance, convenience or capability.
Who benefits — and who may be excluded?	Access, digital inequality, workforce disruption and distribution of risk are part of the technology story, not afterthoughts.

Bottom line

2026–2035 will probably feel less like a sudden leap into science fiction and more like a rapid layering of intelligence, automation and biological precision onto systems we already use.

The biggest effects will come from convergence: AI + robotics, AI + science, genomics + programmable medicine, renewables + storage + smart grids, and neurotechnology + machine learning. Some of the boldest technologies will transform narrow fields before they transform everyday life.

Selected evidence and current-status sources

Stanford Institute for Human-Centered AI. The 2026 AI Index Report. 2026. hai.stanford.edu ↗
World Economic Forum & Frontiers. Top 10 Emerging Technologies of 2026. Published 23 June 2026. weforum.org ↗
Nature. From quantum computing to mRNA therapeutics: seven technologies to watch in 2026. Nature. 21 January 2026. nature.com ↗
Patrick-Krueger KM, Burkhart I, Contreras-Vidal JL. The state of clinical trials of implantable brain–computer interfaces. Nature Reviews Bioengineering. 2025;3:50–67. doi.org ↗
Card NS et al. Long-term independent use of an intracortical brain–computer interface for speech and cursor control. Nature Medicine. Published 15 June 2026. nature.com ↗
Wairagkar M et al. An instantaneous voice-synthesis neuroprosthesis. Nature. 2025;644:145–152. doi.org ↗
US Food and Drug Administration. CASGEVY (exagamglogene autotemcel): regulatory and prescribing information. Updated 2026. fda.gov ↗
3GPP. Technical Highlights: Road to 6G / Release 20 and Release 21 planning. 2025–2026. 3gpp.org ↗
Nature Electronics. A qubit update. 25 July 2025; and Nature Biotechnology. Quantum computing in transition. 6 July 2026. nature.com ↗
NASA. 2026 Moon to Mars architecture updates and Artemis campaign planning. 2026. nasa.gov ↗
UK Parliament. Automated Vehicles Act 2024. legislation.gov.uk ↗

Editorial note: This is an educational horizon scan, updated to August 2026. Development timelines are inherently uncertain. “Likely” and “horizon” statements describe plausible trajectories rather than guarantees, and medical or technological availability varies by country and regulatory system.

FUTURE SCIENCE • OVERVIEW - Transformative Science & Technology 2026–2035